NIH seeks sole-source Thyroseq V3 testing for thyroid nodule FNA samples.
Some language patterns suggest this RFP may be written for a specific incumbent vendor. Review qualification requirements and brand-specific terms carefully before committing bid resources.
The National Institutes of Health (NIH) intends to procure Thyroseq V3 molecular testing services for fine needle aspiration biopsy samples of thyroid nodules. This is a sole-source requirement for the specific Thyroseq V3 test, indicating a tailored need. The test is used to analyze thyroid nodule samples to determine malignancy risk. The contract will be awarded to the sole provider of this test. No other qualifications or experience requirements are specified beyond the ability to perform this specific test.